Millipore Sigma Vibrant Logo

528208 Plasminogen Activator Inhibitor-1, Mutant, Human, Recombinant - Calbiochem

The Plasminogen Activator Inhibitor-1, Mutant, Human, Recombinant controls the biological activity of Plasminogen Activator. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.

SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.

Synonyme: PAI-1, Mutant

Primary Target: Plasminogen Activator
View Products on Sigmaaldrich.com
528208
Preis & Verfügbarkeit

Übersicht

Replacement Information

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
528208-50UG
Verfügbarkeit wird abgerufen...
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      		 Kst.-Ampulle 50 μg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      —
      Bitte erfragen
      		 —
      Description
      OverviewHighly purified preparation of an altered form of human PAI-1 containing four mutated amino acids. Mutant PAI-1 is virtually unable to go latent and is stable at elevated temperature and pH for extended periods of time (t½ = 145 hours at 37°C, pH 7.4). Inhibits uPA (Ki = 5.1 x 106 M-1 sec-1) and tPA (Ki = 7.9 x 105 M-1 sec-1).
      Catalogue Number528208
      Brand Family Calbiochem®
      SynonymsPAI-1, Mutant
      References
      ReferencesBerkenpas, M.B., et al. 1995. EMBO J. 14, 2969.
      Product Information
      ATP CompetitiveN
      FormLiquid
      FormulationIn 100 mM NaCl, 50 mM sodium phosphate buffer, 1 mM EDTA, pH 6.6.
      ReversibleN
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetPlasminogen Activator
      Primary Target K<sub>i</sub>5.1 x 106 M-1 sec-1, 7.9 x 105 M-1 sec-1 against uPA and tPA, respectively
      Purity≥95% by SDS-PAGE assay
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage ≤ -70°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      528208-50UG 04055977196498

      Documentation

      Plasminogen Activator Inhibitor-1, Mutant, Human, Recombinant - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Plasminogen Activator Inhibitor-1, Mutant, Human, Recombinant - Calbiochem Analysenzertifikate

      TitelChargennummer
      528208

      Literatur

      Übersicht
      Berkenpas, M.B., et al. 1995. EMBO J. 14, 2969.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision22-July-2024 JSW
      SynonymsPAI-1, Mutant
      DescriptionHighly purified preparation of an altered form of human PAI-1 containing four mutated amino acids. Mutant PAI-1 is virtually unable to go latent and is stable at elevated temperature and pH for extended periods of time (t½ = 145 h at 37°C, pH 7.4). Inhibits uPA (Ki = 5.1 x 106 M-1sec-1) and tPA (Ki = 7.9 x 105 M-1sec-1).
      FormLiquid
      FormulationIn 100 mM NaCl, 50 mM sodium phosphate buffer, 1 mM EDTA, pH 6.6.
      Concentration Label Please refer to vial label for lot-specific concentration
      Purity≥95% by SDS-PAGE assay
      Storage Avoid freeze/thaw
      ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Toxicity Standard Handling
      ReferencesBerkenpas, M.B., et al. 1995. EMBO J. 14, 2969.